Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "C02KX" (50)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Antihypertensives for Pulmonary Arterial Hypertension (C02KX) 4 products
WHO-DDD
IP
CI
Winrevair 45 mg
5895.82
6356.90
10 %
Lyophilisate and solvent: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
CI
Winrevair 45 mg
2
11790.14
12404.50
10 %
Lyophilisate and solvent: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
CI
Winrevair 60 mg
7864.23
8376.50
10 %
Lyophilisate and solvent: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
CI
Winrevair 60 mg
2
15759.53
16477.10
10 %
Lyophilisate and solvent: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
Bosentan (C02KX01) 11 products
WHO-DDD
DrugBank.ca
IP
CI
Tracleer 62,5 mg
56 Tablet(s)
724.96
800.80
10 %
Coated tablets: Bosentanum 62.5 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Tracleer 62,5 mg
56
724.96
800.80
10 %
Coated tablets: Bosentanum 62.5 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Tracleer 125 mg
56 Tablet(s)
724.96
800.80
10 %
Coated tablets: Bosentanum 125 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Tracleer 125 mg
56
724.96
800.80
10 %
Coated tablets: Bosentanum 125 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Bosentan Spirig HC 62.5 mg
56
659.06
743.70
10 %
Coated tablets: Bosentanum 62.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Bosentan Spirig HC 125 mg
56
659.06
743.70
10 %
Coated tablets: Bosentanum 125 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Bosentan-Mepha 62.5 mg
56
659.06
733.20
10 %
Coated tablets: Bosentanum 62.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bosentan-Mepha 125 mg
56
659.06
733.20
10 %
Coated tablets: Bosentanum 125 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Tracleer
56 Tablet(s)
k.A.
Dispersible Tablets: Bosentanum 32 mg
Janssen-Cilag AG
B
FB
G
IP
CI
Bosentan-Mepha 62.5 mg
14
k.A.
Coated tablets: Bosentanum 62.5 mg
Mepha Pharma AG
B
FB
G
IP
CI
Bosentan-Mepha 125 mg
14
k.A.
Coated tablets: Bosentanum 125 mg
Mepha Pharma AG
B
FB
G
Ambrisentan (C02KX02) 10 products
WHO-DDD
DrugBank.ca
IP
CI
Volibris 5 mg
30 Tablet(s)
954.45
1045.60
10 %
Coated tablets: Ambrisentanum 5 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
IP
CI
Volibris 10 mg
30 Tablet(s)
954.45
1045.60
10 %
Coated tablets: Ambrisentanum 10 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
IP
CI
Ambrisentan Devatis 5 mg
30
811.28
898.75
10 %
Coated tablets: Ambrisentanum 5 mg
Devatis AG
B / SL / SG
FB
G
IP
CI
Ambrisentan Devatis 10 mg
30
811.28
898.75
10 %
Coated tablets: Ambrisentanum 10 mg
Devatis AG
B / SL / SG
FB
G
IP
CI
Ambrisentan OrPha 5 mg
30
811.28
898.75
10 %
Coated tablets: Ambrisentanum 5 mg
OrPha Swiss GmbH
B / SL / SG
FB
G
IP
CI
Ambrisentan OrPha 10 mg
30
811.28
898.75
10 %
Coated tablets: Ambrisentanum 10 mg
OrPha Swiss GmbH
B / SL / SG
FB
G
IP
CI
Ambrisentan-Mepha 5 mg
30
811.28
898.75
10 %
Coated tablets: Ambrisentanum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Ambrisentan-Mepha 10 mg
30
811.28
898.75
10 %
Coated tablets: Ambrisentanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Ambrisentan Devatis 5 mg
10
k.A.
Coated tablets: Ambrisentanum 5 mg
Devatis AG
B
FB
G
IP
CI
Ambrisentan Devatis 10 mg
10
k.A.
Coated tablets: Ambrisentanum 10 mg
Devatis AG
B
FB
G
Macitentan (C02KX04) 8 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Opsumit 10 mg
30 Tablet(s)
2460.62
2692.50
10 %
Coated tablets: Macitentanum 10 mg
Janssen-Cilag AG
B / SL
FB
G
Macitentan Leman 10 mg
30
k.A.
Coated tablets: Macitentanum 10 mg
Leman SKL SA
B
FB
G
Macitentan NOBEL 10 mg
30
k.A.
Coated tablets: Macitentanum 10 mg
NOBEL Pharma Schweiz AG
FB
G
Macitentan Sandoz 10 mg
30
k.A.
Coated tablets: Macitentanum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Macitentan Spirig HC 10 mg
30
k.A.
Coated tablets: Macitentanum 10 mg
Spirig HealthCare AG
B
FB
G
Macitentan Zentiva 10 mg
30
k.A.
Coated tablets: Macitentanum 10 mg
Helvepharm AG
FB
G
Macitentan-Mepha 10 mg
30
k.A.
Coated tablets: Macitentanum 10 mg
Mepha Pharma AG
B
FB
G
Macitentan-Mepha 10 mg
60
k.A.
Coated tablets: Macitentanum 10 mg
Mepha Pharma AG
B
FB
G
Riociguat (C02KX05) 12 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Adempas 0.5 mg
42 Tablet(s)
1156.12
1273.75
10 %
Coated tablets: Riociguatum
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Adempas 1 mg
42 Tablet(s)
1156.12
1273.75
10 %
Coated tablets: Riociguatum 1 mg
Bayer (Schweiz) AG
● 
B / SL
FB
G
IP
CI
PP
Adempas 1.5 mg
42 Tablet(s)
1156.12
1273.75
10 %
Coated tablets: Riociguatum 1.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Adempas 1.5 mg
84 Tablet(s)
2312.23
2531.10
10 %
Coated tablets: Riociguatum 1.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Adempas 2 mg
42 Tablet(s)
1156.12
1273.75
10 %
Coated tablets: Riociguatum 2 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Adempas 2 mg
84 Tablet(s)
2312.23
2531.10
10 %
Coated tablets: Riociguatum 2 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Adempas 2.5 mg
42 Tablet(s)
1156.12
1273.75
10 %
Coated tablets: Riociguatum 2.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Adempas 2.5 mg
84 Tablet(s)
2312.23
2531.10
10 %
Coated tablets: Riociguatum 2.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
Adempas® / Adempas junior
k.A.
Bayer (Schweiz) AG
FB
G
IP
CI
PP
Adempas 1 mg
84 Tablet(s)
2577.34
2819.45
k.A.
Coated tablets: Riociguatum 1 mg
Bayer (Schweiz) AG
B
FB
G
IP
Adempas junior 0.15 mg/ml
k.A.
Bayer (Schweiz) AG
B
FB
G
IP
CI
PP
Adempas 0.5 mg
84 Tablet(s)
k.A.
Coated tablets: Riociguatum
Bayer (Schweiz) AG
B
FB
G
Sotatercept (C02KX06) 4 products
WHO-DDD
IP
CI
Winrevair 45 mg
5895.82
6356.90
10 %
Lyophilisate and solvent: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
CI
Winrevair 45 mg
2
11790.14
12404.50
10 %
Lyophilisate and solvent: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
CI
Winrevair 60 mg
7864.23
8376.50
10 %
Lyophilisate and solvent: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
CI
Winrevair 60 mg
2
15759.53
16477.10
10 %
Lyophilisate and solvent: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
Macitentan and Tadalafil (C02KX54) 1 products
WHO-DDD
IP
CI
Yuvanci 10 mg/40 mg
30
2542.19
2781.20
10 %
Coated tablets: 2 Active Agents
Janssen-Cilag AG
B / SL
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home